Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
Fibrinogen Studies Collaboration None. et al, (2009), Stat Med, 28, 1218 - 1237
Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies.
Fibrinogen Studies Collaboration None., (2009), Stat Med, 28, 1067 - 1092
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
Prospective Studies Collaboration None. et al, (2009), Lancet, 373, 1083 - 1096
Measures to assess the prognostic ability of the stratified Cox proportional hazards model.
Fibrinogen Studies Collaboration None., (2009), Stat Med, 28, 389 - 411
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths (vol 370, pg 1829, 2007)
Lewington S. et al, (2008), LANCET, 372, 292 - 292
Cholesterol, statins, and mortality - Authors' reply
Lewington S. et al, (2008), The Lancet, 371, 1162 - 1163
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
Prospective Studies Collaboration None. et al, (2007), Lancet, 370, 1829 - 1839
Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.
Fibrinogen Studies Collaboration None. et al, (2007), Am J Epidemiol, 166, 867 - 879
Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
Clarke R. et al, (2007), Curr Opin Clin Nutr Metab Care, 10, 32 - 39
Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
Clarke R. et al, (2007), Clin Chem Lab Med, 45, 1575 - 1581
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.
Emerging Risk Factors Collaboration None. et al, (2007), Eur J Epidemiol, 22, 839 - 869
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.
Fibrinogen Studies Collaboration None. et al, (2006), Int J Epidemiol, 35, 1570 - 1578
Lymphotoxin-α gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study
Clarke R. et al, (2006), PLoS Genetics, 2, 0990 - 0996
Trans fatty acids and coronary heart disease - Food labels should list these as well as cholesterol and saturated fat
Clarke R. and Lewington S., (2006), BRITISH MEDICAL JOURNAL, 333, 214 - 214
Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study
Clarke R. et al, (2006), PLoS.Genet., 2
Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
B-Vitamin Treatment Trialists' Collaboration None., (2006), Am Heart J, 151, 282 - 287
The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study.
Woodward M. et al, (2006), Blood Coagul Fibrinolysis, 17, 1 - 5